Hempalta Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Revenue	0.48	0.54	0.44	0.3
Revenue Growth (YoY)	-1.32%	23.77%	44.21%	-
Cost of Revenue	1.06	0.89	0.62	0.34
Gross Profit	-0.57	-0.35	-0.18	-0.04
Selling, General & Admin	2.01	1.67	0.99	1.04
Operating Expenses	2.63	2.25	1.67	1.6
Operating Income	-3.2	-2.59	-1.85	-1.64
Interest Expense	-0.08	-0.14	-0.09	-0.06
Other Non Operating Income (Expenses)	0.05	0.08	0.1	0.02
EBT Excluding Unusual Items	-3.23	-2.65	-1.84	-1.68
Impairment of Goodwill	-2.04	-2.04	-	-
Other Unusual Items	-1.57	-1.8	-	-
Pretax Income	-6.85	-6.5	-1.84	-1.68
Earnings From Continuing Operations	-6.85	-6.5	-1.84	-1.68
Minority Interest in Earnings	0.05	0.05	-	-
Net Income	-6.79	-6.44	-1.84	-1.68
Net Income to Common	-6.79	-6.44	-1.84	-1.68
Shares Outstanding (Basic)	92	71	45	35
Shares Outstanding (Diluted)	92	71	45	35
Shares Change (YoY)	90.70%	59.36%	26.07%	-
EPS (Basic)	-0.07	-0.09	-0.04	-0.05
EPS (Diluted)	-0.07	-0.09	-0.04	-0.05
Free Cash Flow	-2.47	-2.66	-1.37	-3.52
Free Cash Flow Per Share	-0.03	-0.04	-0.03	-0.10
Gross Margin	-119.06%	-64.01%	-41.14%	-14.08%
Operating Margin	-664.91%	-480.45%	-424.55%	-543.50%
Profit Margin	-1410.46%	-1193.65%	-422.56%	-556.08%
Free Cash Flow Margin	-511.79%	-492.36%	-314.17%	-1163.42%
EBITDA	-3.01	-2.31	-1.56	-1.39
D&A For EBITDA	0.19	0.28	0.29	0.25
EBIT	-3.2	-2.59	-1.85	-1.64
Advertising Expenses	-	0.22	0.18	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.